Skip to main content
Contact Us
Subscribe
E-Edition
83°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adma Biologics
(NQ:
ADMA
)
13.78
+0.42 (+3.16%)
Streaming Delayed Price
Updated: 12:57 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Adma Biologics
< Previous
1
2
3
4
5
Next >
Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
July 18, 2024
Via
Benzinga
Biotech Arvinas Stock Earns 82 RS Rating
July 17, 2024
The Relative Strength (RS) Rating for Arvinas stock entered a new percentile Wednesday, with a rise from 62 to 82.
Via
Investor's Business Daily
Denali Therapeutics Stock Gets Technical Rating Upgrade
July 16, 2024
Denali Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
3 Millionaire-Making Stock Picks With Astounding Growth Potential
July 13, 2024
Owning millionaire-making stocks can be a life changer. Look no further than these three companies which are full of potential.
Via
InvestorPlace
How Is The Market Feeling About ADMA Biologics?
July 11, 2024
Via
Benzinga
Bull Run Alert: 3 Stocks Set to Soar in the Coming Months
July 11, 2024
Get ready for the next bull run with these stocks. All three are showing impressive growth and massive returns.
Via
InvestorPlace
Expert Ratings For ADMA Biologics
July 09, 2024
Via
Benzinga
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
June 20, 2024
Via
Benzinga
ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results
May 10, 2024
Via
Benzinga
UroGen Pharma Stock Earns 91 RS Rating
June 27, 2024
UroGen Pharma stock had its Relative Strength (RS) Rating upgraded to 91 Thursday, up from 87 a day earlier.
Via
Investor's Business Daily
Arcellx Stock Earns Relative Strength Rating Upgrade
June 21, 2024
One key metric to look for in a stock is an 80-plus Relative Strength Rating. Arcellx stock cleared that benchmark Friday, jumping to 83.
Via
Investor's Business Daily
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
June 20, 2024
Intra-Cellular Therapies sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Neurocrine Biosciences has long been known for its blockbuster drug Ingrezza. It's diversifying, developing multiple drugs in related areas.
Via
Investor's Business Daily
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
June 12, 2024
On Wednesday, Madrigal Pharmaceuticals stock earned an upgrade to its Relative Strength (RS) Rating, from 74 to 90.
Via
Investor's Business Daily
Krystal Biotech Stock Sees RS Rating Jump To 91
June 11, 2024
On Tuesday, Krystal Biotech stock cleared a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88.
Via
Investor's Business Daily
A Closer Look at 6 Analyst Recommendations For ADMA Biologics
March 26, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For ADMA Biologics
February 29, 2024
Via
Benzinga
Recap: ADMA Biologics Q4 Earnings
February 28, 2024
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
May 10, 2024
Via
Benzinga
Earnings Preview For ADMA Biologics
February 27, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For ADMA Biologics
January 22, 2024
Via
Benzinga
ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
ADMA stock results show that ADMA Biologics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
Chart Of The Day: ADMA Biologics - Hitting New Highs
May 06, 2024
100% technical buy signals 8 new highs and up 7.24% in the last month 110.10+ Weighted Alpha
Via
Talk Markets
Why Adma Biologics Stock Crushed the Market on Friday
November 17, 2023
The network of FDA-approved collection facilities continues to grow.
Via
The Motley Fool
Why Adma Biologics Was Trouncing the Market Today
November 09, 2023
The company beat analyst estimates for both revenue and profitability, and raised revenue guidance.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 08, 2023
Via
Benzinga
Earnings Preview: ADMA Biologics
November 07, 2023
Via
Benzinga
Why Shares of ADMA Biologics Are Climbing Thursday
August 10, 2023
The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed.
Via
The Motley Fool
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.